Comerica Securities’s Teladoc Health TDOC Stock Holding History

Comerica Securities’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-27	Closed	-$639	–	1305
2022 Q4	$639	Buy	+27	New	+$728	﹤0.01%	1395

Other funds holding TDOC

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Comerica Securities's TDOC Position: Q1 2023 in Review

Comerica Securities sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 27 shares — an estimated $639 sold.

Comerica Securities first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $639 in Q4 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

Comerica Securities reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 27 Teladoc Health shares in Q1 2023, an estimated $639.
Comerica Securities first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
Comerica Securities's Teladoc Health position peaked at $639 in Q4 2022.
429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.